PAION AG (PA8) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Sep 2010)

FII

0.06%

Held by 1 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.24
The company has been able to generate a Return on Equity (avg) of 6.56% signifying low profitability per unit of shareholders funds

The company has declared negative results in Jun'2023 after 2 consecutive positive quarters

Risky -

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 0 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-5.28

Return on Equity

920.17%

Price to Book

-0.03

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Dec 2015)

Net Profit:

-8 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-99.45%

6 Months

-99.45%

1 Year

-99.45%

2 Years

-99.45%

3 Years

-99.56%

4 Years

-99.49%

5 Years

-99.46%

PAION AG for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-56.45%

EBIT Growth (5y)

-213.11%

EBIT to Interest (avg)

-6.24

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-5.28

Sales to Capital Employed (avg)

0.00

Tax Ratio

20.22%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.06%

ROCE (avg)

158.31%

ROE (avg)

6.56%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.07

EV to EBIT

-0.47

EV to EBITDA

-0.47

EV to Capital Employed

1.25

EV to Sales

16.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-266.95%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2010

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is -100.00% vs -40.74% in Dec 2014",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2015 is -178.57% vs -315.38% in Dec 2014",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'15",
        "Dec'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "1.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.60",
          "val2": "-4.30",
          "chgp": "-123.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.80",
          "val2": "-2.80",
          "chgp": "-178.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-354,881.10%",
          "val2": "-2,743.30%",
          "chgp": "-35,213.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 367.61% vs -63.96% in Dec 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 97.25% vs -1,090.91% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.20",
          "val2": "7.10",
          "chgp": "367.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.70",
          "val2": "-19.40",
          "chgp": "119.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.80",
          "val2": "2.10",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-21.80",
          "chgp": "97.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "60.40%",
          "val2": "-2,949.60%",
          "chgp": "301.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'15 - YoY

Dec'15

Dec'14

Change(%)

Net Sales

0.00

1.60

-100.00%

Operating Profit (PBDIT) excl Other Income

-9.60

-4.30

-123.26%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-7.80

-2.80

-178.57%

Operating Profit Margin (Excl OI)

-354,881.10%

-2,743.30%

-35,213.78%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2015 is -100.00% vs -40.74% in Dec 2014

Consolidated Net Profit

YoY Growth in quarter ended Dec 2015 is -178.57% vs -315.38% in Dec 2014

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

33.20

7.10

367.61%

Operating Profit (PBDIT) excl Other Income

3.70

-19.40

119.07%

Interest

2.80

2.10

33.33%

Exceptional Items

0.00

Consolidate Net Profit

-0.60

-21.80

97.25%

Operating Profit Margin (Excl OI)

60.40%

-2,949.60%

301.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is 367.61% vs -63.96% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 97.25% vs -1,090.91% in Dec 2021

All Annual Results

Company CV

About PAION AG

PAION AG

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available